127 related articles for article (PubMed ID: 19631839)
21. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
[TBL] [Abstract][Full Text] [Related]
22. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
[TBL] [Abstract][Full Text] [Related]
23. [The REACH registry: baseline and 1-year results].
Esmatjes E; Blanco AJ
Med Clin (Barc); 2009 Sep; 132 Suppl 2():5-9. PubMed ID: 19631831
[TBL] [Abstract][Full Text] [Related]
24. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
25. [Implications of the REACH registry for internal medicine].
Ramos Salado JL
Med Clin (Barc); 2009 Sep; 132 Suppl 2():34-7. PubMed ID: 19631837
[TBL] [Abstract][Full Text] [Related]
26. [Implications of the REACH registry for endocrinologists].
Alonso G
Med Clin (Barc); 2009 Sep; 132 Suppl 2():21-4. PubMed ID: 19631834
[TBL] [Abstract][Full Text] [Related]
27. [Risk factor control and treatment of atherothrombosis. Spain REACH Registry].
Suárez C; Cairols M; Castillo J; Esmatjes E; Sala J; Llobet X; Palma JC;
Med Clin (Barc); 2007 Oct; 129(12):446-50. PubMed ID: 17953908
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two-year outcomes in patients undergoing isolated coronary artery bypass grafting with and without peripheral artery disease.
Popovic B; Arnould MA; Selton-Suty C; Latarche C; Angioi M; Carteaux JP; Villemot JP; Aliot E
Am J Cardiol; 2009 Nov; 104(10):1377-82. PubMed ID: 19892053
[TBL] [Abstract][Full Text] [Related]
30. [Economic burden of cancer in South Korea for the year 2005].
Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
[TBL] [Abstract][Full Text] [Related]
31. Minimized analysis of costs applied to antimicrobial consumption in a rural area.
Sánchez CC; Nájera LH; Inchaurregui LC
Pharmacoepidemiol Drug Saf; 2001; 10(2):143-8. PubMed ID: 11499853
[TBL] [Abstract][Full Text] [Related]
32. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
Yakubov S
Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
[TBL] [Abstract][Full Text] [Related]
33. Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population.
Doan QV; Lange SM; Elfant A; Aguilar D; Reyes E; Lynn RB; Dubois RW
J Med Econ; 2008; 11(1):23-40. PubMed ID: 19450108
[TBL] [Abstract][Full Text] [Related]
34. Economic burden of venous thromboembolism in hospitalized patients.
Dobesh PP
Pharmacotherapy; 2009 Aug; 29(8):943-53. PubMed ID: 19637948
[TBL] [Abstract][Full Text] [Related]
35. Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry.
Yeo TC; Chan YH; Low LP; Venketasubramanian N; Lim SC; Tay JC; Tan RS; Eng P; Lingamanaicker J;
Ann Acad Med Singap; 2008 May; 37(5):365-71. PubMed ID: 18536821
[TBL] [Abstract][Full Text] [Related]
36. Costing of severe pneumonia in hospitalized infants and children aged 2-36 months, at a secondary and tertiary level hospital of a not-for-profit organization.
Madsen HO; Hanehøj M; Das AR; Moses PD; Rose W; Puliyel M; Konradsen F; John KR; Bose A
Trop Med Int Health; 2009 Oct; 14(10):1315-22. PubMed ID: 19719464
[TBL] [Abstract][Full Text] [Related]
37. The comparative medical costs of atherothrombotic disease in European countries.
Levy E; Gabriel S; Dinet J
Pharmacoeconomics; 2003; 21(9):651-9. PubMed ID: 12807366
[TBL] [Abstract][Full Text] [Related]
38. [Optimizing overall risk reduction: implications of the REACH registry. Introduction].
Steg G
Med Clin (Barc); 2009 Sep; 132 Suppl 2():1. PubMed ID: 19798791
[No Abstract] [Full Text] [Related]
39. Economic burden of psoriasis compared to the general population and stratified by disease severity.
Yu AP; Tang J; Xie J; Wu EQ; Gupta SR; Bao Y; Mulani PM
Curr Med Res Opin; 2009 Oct; 25(10):2429-38. PubMed ID: 19663687
[TBL] [Abstract][Full Text] [Related]
40. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
